Skip to main content
SpringerLink
Log in

Nutritional therapy for Crohn’s disease in Japan

  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

In Japan, nutritional therapy as both a primary and as a secondary treatment is widely used for Crohn’s disease (CD). The rationale for its use is based on a variety of reasons. The first is its ability to induce remission and to ameliorate the activity of intestinal lesions in the short term by enterai (EN) or by parenteral nutritional therapy in which overexpressions of chemokine receptors in an active stage are decreased significantly in the remission stage. Second is its ability to maintain remission over the long term through home-based enterai nutrition in which tube feeding during the nighttime is encouraged. Third is its ability to reduce the steroid dosage over the period of a long-term treatment course. However, several disadvantages of this therapy such as unpalatability and sluggish effect have been pointed out. Several studies have attempted to resolve this issue and determine the best components of EN, especially in fat composition. Some data have been suggestive of too much long-chained fatty acid having a hazardous effect on EN’s clinical efficacy because it works as a precursor of inflammatory prostaglandins. Our recent data show that medium-chained triglyceride did not have such a hazardous effect on clinical efficacy. Several studies suggested that the patient factors that were resistant to inducing remission in the short term were a long period of suffering CD, a high activity (on Crohn’s Disease Activity Index, CDAI), hemorrhagic colitis, and colitis with marked cobblestoning. Japanese guidelines for the treatment of CD recommended nutritional therapy as a first-line therapy and as a maintenance therapy after inducing remission. This treatment policy has led to Japanese CD patients having lower mortality rates than that of patients who do not receive EN. If this therapy could be combined with other drug therapies, including strong immunosuppressants, treatment strategies would be improved over those we have at present.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yao T. Criteria for the diagnosis of Crohn’s disease (preliminary proposal). In: Muto T, editor. Annual report of the Research Committee of Inflammatory Bowel Disease. Tokyo: The Ministry of Health and Welfare of Japan; 1995. p. 63–6.

    Google Scholar 

  2. Yao T, Matsui T, Hiwatashi N. Crohn’s disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000;43(suppl 10): S85–93.

    Article  PubMed  CAS  Google Scholar 

  3. Hiwatashi N. Guideline for the treatment of Crohn’s disease (preliminary proposal). In: Shimoyama T, editor. Annual report of the Research Committee of Inflammatory Bowel Disease. Tokyo: the Ministry of Health, Welfare and Labor of Japan; 2002. p. 59–61.

    Google Scholar 

  4. Fukuda Y, Kosaka T, Okui M, Hirakawa H, Shimoyama T. Efficacy of nutritional therapy for active Crohn’s disease. J Gastroenterol 1995;30 (suppl 8): 83–7.

    PubMed  Google Scholar 

  5. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn’s disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to The increased incidence of Crohn’s disease in Japan. Am J Clin Nutr 1996; 63: 741–5.

    PubMed  CAS  Google Scholar 

  6. Hiwatashi N. Enterai nutrition for Crohn’s disease in Japan. Dis Colon Rectum 1997; 40 (suppl): s48–53.

    Article  PubMed  CAS  Google Scholar 

  7. Okada M, Yao T, Yamamoto T, Takenaka K, Imamura K, Maeda K, et al. Controlled trial comparing an elemental diet with prednisolone in the treatment of active Crohn’s disease. Hepatogastroenterology 1990; 37: 72–80.

    PubMed  CAS  Google Scholar 

  8. Ueki M, Matsui T, Yamada M, Sakurai T, Yao T, Okada M, et al. Randomized controlled trial of amino acid based diet versus oligopeptide based diet in enterai nutritional therapy of active Crohn’s disease. Jpn J Gastroenterol 1994; 91: 1415–25.

    CAS  Google Scholar 

  9. Koga H, Iida M, Aoyagi K, Matsui T, Fujishima M. Long-term efficacy of low residue diet for the maintenance of remission in patients with Crohn’s disease. Jpn J Gastroenterol 1993; 90: 2882–8.

    CAS  Google Scholar 

  10. Matsui T, Ueki M, Yamada M, Sakurai T, Yao T. Indications and options of nutritional treatment for Crohn’s disease; a comparison of elemental and polymeric diets. J Gastroenterol 1995; 30(suppl 8): 95–7.

    PubMed  Google Scholar 

  11. Sakurai T, Matsui T, Yao T, Takagi Y, Hirai F, Aoyagi K, et al. Short-term efficacy of enterai nutrition in the treatment of active Crohn’s disease: a randomized, controlled trial comparing nutrient formulas. JPEN J Parenter Enterai Nutr 2002; 26: 98–103.

    Article  CAS  Google Scholar 

  12. Kobayashi K, Katsumata T, Yokoyama K, Takahashi H, Igarashi M, Saigenzi K. A randomized controlled study of total parenteral nutrition and enterai nutrition by elemental diet and polymeric diet as primary therapy in active phase of Crohn’s disease. Jpn J Gastroenterol 1998; 96: 1212–21.

    Google Scholar 

  13. Messori A, Trallori G, D’Albasio G, Mikka M, Vannozzi G, Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn’s disease. A meta-analysis. Scand J Gastroenterol 1996; 31: 267–72.

    Article  CAS  Google Scholar 

  14. Verma S, Brown S, Kirkwood B, Giaffer MH. Polymeric versus elemental diet as primary treatment in active Crohn’s disease: a randomized, double blind trial. Am J Gastroenterol 2000; 95: 735–9.

    Article  PubMed  CAS  Google Scholar 

  15. Khoshoo V, Reinfen R, Neuman MG, Griffiths Pencharz PB. Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn’s disease. JPEN J Parenter Enterai Nutr 1996; 20: 401–5.

    Article  CAS  Google Scholar 

  16. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Metaanalysis of enterai nutrition as a primary treatment of active Crohn’s disease. Gastroenterology 1995;108: 1056–67.

    Article  PubMed  CAS  Google Scholar 

  17. Gassull MA, Fernandez-Banares F, Cabre E, Papo M, Giaffer MH, Sachez-Lambrana JL, et al. Fat composition may be a clue to explain the primary therapeutic effect of enterai nutrition in Crohn’s disease: results of a double blind randomized multicentre trial. Gut 2002; 51: 164–8.

    Article  PubMed  CAS  Google Scholar 

  18. Gonzalez-Huix F, de Leon R, Fernanez-Banares F, Esteve M, Cabre E, Acero D, et al. Polymeric enterai diets as primary treatment of active Crohn’s disease: a prospective steroid controlled trial. Gut 1993; 34: 778–82.

    Article  PubMed  CAS  Google Scholar 

  19. Forbes A. Review: Crohn’s disease-the role of nutritional therapy. Aliment Pharmacol Ther 2002; 16(suppl 4): 48–52.

    Article  PubMed  Google Scholar 

  20. Jo Y, Matsumoto T, Yada S, Fujisawa K, Esaki M, Onai N, et al. CCR4 is up-regulated chemokine receptor of peripheral blood memory CD4+ T-cell in Crohn’s disease. Clin Exp Immunol 2003; 132: 332–8.

    Article  PubMed  CAS  Google Scholar 

  21. Furukawa H, Yamada M, Sakurai T, Takenaka K, Matsui T, Yao T. Short-term remission rates of enterai nutrition and its effecting factors in patients with Crohn’s disease. Jpn J Gastroenterol 1997; 94: 813–25.

    CAS  Google Scholar 

  22. Yamada M, Sakurai T, Furukawa H, Matsui T, Yao T. Refractory factors of enterai nutrition in inducing remission in patients with Crohn’s disease. Jpn J Colo-Proctology 1998; 51: 6–17.

    Google Scholar 

  23. Munkholm P, Langholz E, Davidson M, Binder V. Frequency of glucocorticoid resistance and dependency in Crohn’s disease. Gut 1994; 35: 360–2.

    Article  PubMed  CAS  Google Scholar 

  24. Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001; 121: 255–60.

    Article  PubMed  CAS  Google Scholar 

  25. Rutgeerts PJ. Review article: the limitation of corticosteroid therapy in Crohn’s disease. Aliment Pharmacol Ther 2001; 15: 1515–25.

    Article  PubMed  CAS  Google Scholar 

  26. Winship DH, Summers RW, Singleton JW, Best WR, Becktel JM, Lenk LF, et al. National Cooperative Crohn’s Disease Study: study design and conduct of the study. Gastroenterology 1979; 77: 829–920.

    PubMed  CAS  Google Scholar 

  27. Wilschanski M, Sherma P, Penchaz P, Penchanz P, Davis L, Corey M, et al. Supplementary enterai nutrition maintains remission in paediatric Crohn’s disease. Gut 1996;38: 543–8.

    Article  PubMed  CAS  Google Scholar 

  28. Kobayashi K, Katsumate T, Igarashi M, Yoshizawa S, Sata M, Saigenzi K. Clinical usefulness of nutritional treatment for morphlogical findings of long-standing Crohn’s disease-especially focusing on comparison with drug treatment. Stomach Intest 2004; 39: 145–54.

    Google Scholar 

  29. Uno H, Yao T, Matsui T, Sakurai T, Iida M, Matsumoto T, et al. Mortality and cause of death in Japanese patients with Crohn’s disease. Dis Colon Rectum 2003; 46(suppl): s15–21.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Fukuoka University Chikushi Hospital, 377-1 Chikushino, Zokumyouin, 818-8502, Chikushino, Japan

    Toshiyuki Matstji, Toshihiro Sakurai & Tsuneyoshi Yao

Authors
  1. Toshiyuki Matstji
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshihiro Sakurai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tsuneyoshi Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matstji, T., Sakurai, T. & Yao, T. Nutritional therapy for Crohn’s disease in Japan. J Gastroenterol 40 (Suppl 16), 25–31 (2005). https://doi.org/10.1007/BF02990575

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02990575

Key words

Search

Navigation